Recombinant human erythropoietin, and myocardial and cerebral acute ischemia: implications for clinical use.

Recombinant human erythropoietin has been used for more than two decades in clinical practice with promising results in the treatment of anemia associated with chronic renal insufficiency and in patients with cancer. Recent evidence has uncovered new nonhematopoietic functions of this protein and ha...

Full description

Bibliographic Details
Main Authors: Rafael Alejandro Gómez Baute, Liermis Dita Salabert, Yaney González Yglesias, Tamara Guerra Alfonso, Maritza Cabrera Zamora
Format: Article
Language:Spanish
Published: Centro Provincial de Información de Ciencias Médicas. Cienfuegos 2010-07-01
Series:Medisur
Subjects:
Online Access:http://medisur.sld.cu/index.php/medisur/article/view/1158
_version_ 1797278083509649408
author Rafael Alejandro Gómez Baute
Liermis Dita Salabert
Yaney González Yglesias
Tamara Guerra Alfonso
Maritza Cabrera Zamora
author_facet Rafael Alejandro Gómez Baute
Liermis Dita Salabert
Yaney González Yglesias
Tamara Guerra Alfonso
Maritza Cabrera Zamora
author_sort Rafael Alejandro Gómez Baute
collection DOAJ
description Recombinant human erythropoietin has been used for more than two decades in clinical practice with promising results in the treatment of anemia associated with chronic renal insufficiency and in patients with cancer. Recent evidence has uncovered new nonhematopoietic functions of this protein and have brought new hope in the treatment of diseases with ischemic component. In the present review is rife with detail about these new features in the light of new discoveries and explores the therapeutic opportunities offered by these new scientific evidence.
first_indexed 2024-03-07T15:58:21Z
format Article
id doaj.art-aa982b927d78480c840d2e5836a83904
institution Directory Open Access Journal
issn 1727-897X
language Spanish
last_indexed 2024-03-07T15:58:21Z
publishDate 2010-07-01
publisher Centro Provincial de Información de Ciencias Médicas. Cienfuegos
record_format Article
series Medisur
spelling doaj.art-aa982b927d78480c840d2e5836a839042024-03-04T23:09:38ZspaCentro Provincial de Información de Ciencias Médicas. CienfuegosMedisur1727-897X2010-07-0183164171596Recombinant human erythropoietin, and myocardial and cerebral acute ischemia: implications for clinical use.Rafael Alejandro Gómez Baute0Liermis Dita Salabert1Yaney González Yglesias2Tamara Guerra Alfonso3Maritza Cabrera Zamora4Hospital General Universitario "Dr. Gustavo Aldereguía Lima". Cienfuegos.Hospital General Universitario "Dr. Gustavo Aldereguía Lima". Cienfuegos.Hospital General Universitario "Dr. Gustavo Aldereguía Lima". Cienfuegos.Hospital General Universitario "Dr. Gustavo Aldereguía Lima". Cienfuegos.Hospital General Universitario "Dr. Gustavo Aldereguía Lima" Cienfuegos.Recombinant human erythropoietin has been used for more than two decades in clinical practice with promising results in the treatment of anemia associated with chronic renal insufficiency and in patients with cancer. Recent evidence has uncovered new nonhematopoietic functions of this protein and have brought new hope in the treatment of diseases with ischemic component. In the present review is rife with detail about these new features in the light of new discoveries and explores the therapeutic opportunities offered by these new scientific evidence.http://medisur.sld.cu/index.php/medisur/article/view/1158eritropoyetina recombinanteisquemia encefálicaisquemia miocárdica
spellingShingle Rafael Alejandro Gómez Baute
Liermis Dita Salabert
Yaney González Yglesias
Tamara Guerra Alfonso
Maritza Cabrera Zamora
Recombinant human erythropoietin, and myocardial and cerebral acute ischemia: implications for clinical use.
Medisur
eritropoyetina recombinante
isquemia encefálica
isquemia miocárdica
title Recombinant human erythropoietin, and myocardial and cerebral acute ischemia: implications for clinical use.
title_full Recombinant human erythropoietin, and myocardial and cerebral acute ischemia: implications for clinical use.
title_fullStr Recombinant human erythropoietin, and myocardial and cerebral acute ischemia: implications for clinical use.
title_full_unstemmed Recombinant human erythropoietin, and myocardial and cerebral acute ischemia: implications for clinical use.
title_short Recombinant human erythropoietin, and myocardial and cerebral acute ischemia: implications for clinical use.
title_sort recombinant human erythropoietin and myocardial and cerebral acute ischemia implications for clinical use
topic eritropoyetina recombinante
isquemia encefálica
isquemia miocárdica
url http://medisur.sld.cu/index.php/medisur/article/view/1158
work_keys_str_mv AT rafaelalejandrogomezbaute recombinanthumanerythropoietinandmyocardialandcerebralacuteischemiaimplicationsforclinicaluse
AT liermisditasalabert recombinanthumanerythropoietinandmyocardialandcerebralacuteischemiaimplicationsforclinicaluse
AT yaneygonzalezyglesias recombinanthumanerythropoietinandmyocardialandcerebralacuteischemiaimplicationsforclinicaluse
AT tamaraguerraalfonso recombinanthumanerythropoietinandmyocardialandcerebralacuteischemiaimplicationsforclinicaluse
AT maritzacabrerazamora recombinanthumanerythropoietinandmyocardialandcerebralacuteischemiaimplicationsforclinicaluse